ALIFBS Stock Overview Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
AddLife AB (publ) Competitors Price History & Performance
Summary of share price highs, lows and changes for AddLife Historical stock prices Current Share Price SEK 145.75 52 Week High SEK 163.45 52 Week Low SEK 140.90 Beta 1.34 1 Month Change 0% 3 Month Change n/a 1 Year Change n/a 3 Year Change -60.82% 5 Year Change 101.73% Change since IPO 274.92%
Recent News & Updates AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025
AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025 Jun 27
AddLife AB (publ) Approves Dividend, Payable on 16 May 2024 May 09
AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025 Apr 24
AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024 Mar 06 AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024 See more updates AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025
AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025 Jun 27
AddLife AB (publ) Approves Dividend, Payable on 16 May 2024 May 09
AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025 Apr 24
AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024 Mar 06 AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024
AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024 Oct 27
AddLife AB (publ), Annual General Meeting, May 08, 2024 Oct 20
Second quarter 2023 earnings released: EPS: kr0.27 (vs kr0.61 in 2Q 2022) Jul 16
Independent Director recently bought kr12m worth of stock May 28
Investor sentiment improves as stock rises 37% May 17
President & CEO recently bought kr129k worth of stock May 17
Addlife AB (Publ) Declares Dividend May 06
Upcoming dividend of kr1.20 per share at 1.0% yield Apr 28
President & CEO recently bought kr139k worth of stock Mar 29
President & CEO recently bought kr112k worth of stock Mar 09
AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022 Feb 03
President & CEO recently bought kr285k worth of stock Dec 17
Håkan Roos acquired a 0.246285% stake in AddLife AB (publ) for SEK 30 million. Nov 02 AddLife AB (publ) to Report First Half, 2023 Results on Jul 14, 2023
AddLife AB (publ) to Report Q1, 2023 Results on Apr 26, 2023 Sep 30
Second quarter 2022 earnings released Jul 16
Now 23% undervalued after recent price drop Jul 01
Investor sentiment deteriorated over the past week Jun 16
CFO & Business Area Manager of Medtech recently sold kr8.5m worth of stock Jun 06
Addlife AB (Publ) Approves Dividend, Payable on 12 May 2022 May 06 AddLife AB (publ) Appoints Fredrik Dalborg as President
Full year 2021 earnings released: EPS: kr6.02 (vs kr4.62 in FY 2020) Apr 03
AddLife AB (publ) (OM: ALIF B) acquired O'Flynn Medical Limited. Apr 03
Addlife AB (Publ) Proposes Dividend, Payable on 12 May 2022 Mar 31
Investor sentiment improved over the past week Mar 22
AddLife AB (publ) (OM:ALIF B) completed the acqusitions of Telia Health Monitoring. Mar 03
President & CEO recently bought kr5.8m worth of stock Feb 08
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 05
Addlife AB (Publ) Proposes Dividend Feb 05
Addlife AB (Publ) Announces Step Down of Kristina Willgård as Chief Executive Officer Feb 04
AddLife AB (publ) (OM:ALIF B) completed the acquisition of MBA Incorporado S.A from Alantra Private Equity. Jan 22
Investor sentiment deteriorated over the past week Jan 08
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire MBA Incorporado S.A from Alantra Private Equity for approximately €110 million. Dec 23
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Telia Health Monitoring. Dec 22
Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million. Dec 02
President & CEO recently sold kr32m worth of stock Oct 30
Third quarter 2021 earnings released Oct 23
Investor sentiment deteriorated over the past week Sep 24
Independent Chairman recently sold kr11m worth of stock Sep 22
AddLife AB (publ) (OM:ALIF B) acquired Bio-Connect BV. Sep 02
Investor sentiment improved over the past week Aug 26
Chief Financial Officer recently sold kr106k worth of stock Aug 21
Independent Chairman recently sold kr7.0m worth of stock Aug 08
Second quarter 2021 earnings released: EPS kr1.46 (vs kr1.07 in 2Q 2020) Jul 16
Investor sentiment improved over the past week Jun 11
Chief Financial Officer recently sold kr14m worth of stock May 09
Independent Director has left the company May 08
AddLife AB (publ) Approves Dividend, Payable on 12 May 2021 May 06
First quarter 2021 earnings released Apr 30
Upcoming dividend of kr1.50 per share Apr 29
AddLife AB (Publ) Provides Earnings Guidance for 2021 Apr 13
New 90-day high: kr175 Feb 26
Full year 2020 earnings released: EPS kr4.62 (vs kr1.27 in FY 2019) Feb 05
New 90-day high: kr169 Feb 05
AddLife AB (publ) to Report Fiscal Year 2021 Results on Feb 03, 2022 Feb 04
New 90-day high: kr150 Jan 24
Insider recently bought kr692k worth of stock Dec 23
AddLife AB (publ) (OM:ALIF B) completed the acquisition of the advanced surgery business of SIAD Healthcare S.p.A. Dec 03
AddLife AB (publ) to Report Nine Months, 2021 Results on Oct 22, 2021 Nov 03 AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Zafe Care Systems Ab.
AddLife AB (publ) (OM:ALIF B) signed an agreement to acquire Ropox A/S. Oct 02 Shareholder Returns ALIFBS GB Life Sciences GB Market 7D 0% -6.8% -2.2% 1Y n/a -26.2% 2.4%
See full shareholder returns
Return vs Market: Insufficient data to determine how ALIFBS performed against the UK Market .
Price Volatility Is ALIFBS's price volatile compared to industry and market? ALIFBS volatility ALIFBS Average Weekly Movement n/a Life Sciences Industry Average Movement 7.3% Market Average Movement 4.8% 10% most volatile stocks in GB Market 10.5% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: ALIFBS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine ALIFBS's volatility change over the past year.
About the Company Founded Employees CEO Website 1906 2,356 Fredrik Dalborg www.add.life
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments.
Show more AddLife AB (publ) Fundamentals Summary How do AddLife's earnings and revenue compare to its market cap? ALIFBS fundamental statistics Market cap SEK 16.67b Earnings (TTM ) SEK 117.00m Revenue (TTM ) SEK 10.01b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ALIFBS income statement (TTM ) Revenue SEK 10.01b Cost of Revenue SEK 6.28b Gross Profit SEK 3.74b Other Expenses SEK 3.62b Earnings SEK 117.00m
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 05, 2025
Earnings per share (EPS) 0.96 Gross Margin 37.31% Net Profit Margin 1.17% Debt/Equity Ratio 95.9%
How did ALIFBS perform over the long term?
See historical performance and comparison Dividends
0.4% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 12:26 End of Day Share Price 2024/10/23 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources AddLife AB (publ) is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Karl Norén Danske Bank Gustav Berneblad Nordea Markets
Show 0 more analysts 